CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lumiera Health Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lumiera Health Inc
4500 Blvd. Kimber
Phone: (450) 926-2442p:450 926-2442 SAINT-HUBERT, QC  J3Y 8K5  Canada Ticker: NHP.HNHP.H
Business Summary
Lumiera Health Inc. is a Canadian company that specializes in the development and commercialization of natural health products. Its brands consist of Holizen Laboratories, Awaye pain relief cream, and Bazzzics. Through its Holizen Laboratories division, the Company sells both oral and topical formulations to help manage a range of therapeutic needs, including a new generation of natural sleep-aids. The Company is also engaged in commercializing a topical product line acting on the endocannabinoid system, without the use of cannabis, which provides a solution for chronic pain and inflammation. Awaye is a topical product that works with the body's own endocannibinoid pain defense system and provides relief from both acute and chronic pain. Part of the Holizen portfolio, Bazzzics is a line of three formulas composed of sedative plant extracts that can be combined to address the customer's specific sleeping needs: pre-sleep serenity, fall asleep, and stay asleep.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
8/31/202311/30/2022Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board KevinCole 1/1/2020 1/1/2020
Chief Executive Officer, Director CarlosPonce
Interim Chief Financial Officer, Director SimonCastonguay
5 additional Officers and Directors records available in full report.

Business Names
Business Name
EMS.H
EMS.P
Lumiera Health Innovation Inc.
NHP
NHP.H

General Information
Outstanding Shares: 169,965,217 (As of 8/31/2023)
Stock Exchange: NEX
Fax Number: (450) 926-2452


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, September 14, 2024